LB
60
4
DOW
43
-3
EQIX
75
-2
COP
47
2
MOS
43
-5
WU
34
-2
WM
82
2
GS
78
3
VFC
50
-2
EFX
41
-5
HIG
75
4
HCA
48
2
NWSA
63
-4
PM
66
4
EW
46
3
INTU
56
3
XOM
40
-7
WYNN
38
-3
ORLY
66
4
FCX
57
-2
LB
60
4
DOW
43
-3
EQIX
75
-2
COP
47
2
MOS
43
-5
WU
34
-2
WM
82
2
GS
78
3
VFC
50
-2
EFX
41
-5
HIG
75
4
HCA
48
2
NWSA
63
-4
PM
66
4
EW
46
3
INTU
56
3
XOM
40
-7
WYNN
38
-3
ORLY
66
4
FCX
57
-2
Financhill
Back

PIMCO Municipal Income Fund II Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
32

PML
PIMCO Municipal Income Fund II

Last Price:
8.77
Seasonality Move:
1.92%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.49
Seasonality Move:
14.88%
Sell
32
PIMCO Municipal Income Fund II (PML) is a Sell

Is PIMCO Municipal Income Fund II a Buy, Sell or Hold?

  • The current PIMCO Municipal Income Fund II [PML] share price is $8.66. The Score for PML is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PML is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PML Stock Price Chart

What is PIMCO Municipal Income Fund II's stock price today?

  • The PIMCO Municipal Income Fund II share price today is $8.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PML is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PML Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 40.55 Sell
Chaikin Money Flow: 34754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.67 - 8.99) Sell
Bollinger Bands (100): (8.59 - 9.15) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

PML Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.65 Buy
20-day SMA: 8.81 Sell
50-day SMA: 9.04 Sell
200-day SMA: 8.65 Buy
8-day EMA: 8.68 Sell
20-day EMA: 8.79 Sell
50-day EMA: 8.9 Sell
200-day EMA: 8.74 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

PIMCO Municipal Income Fund II Earnings Growth & PML Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

PIMCO Municipal Income Fund II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):